Chemically engineered peptides, designed and developed by a team of researchers at Rensselaer Polytechnic Institute, could prove valuable in the battle against some of the most persistent human health challenges. The team’s findings, recently published in Nature Scientific Reports, demonstrate how researchers can engineer peptides capable of selectively and specifically binding to polysialic acid (PSA) — a carbohydrate that is present in many human cells and plays a key role in various physiological and pathological processes, including neurological development and disease progression. Learn More